Lowering the dose of anti-cancer drugs well below the standard treatment threshold has shown promise in improving tumours’ response to...
Vous n'êtes pas connecté
Researchers at the Francis Crick Institute, UK, in collaboration with Revolution Medicines, have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive tumours. Their findings show that targeting tumours in different ways simultaneously might increase response to treatments. In research published today in Nature Communications [...]
Lowering the dose of anti-cancer drugs well below the standard treatment threshold has shown promise in improving tumours’ response to...
Lowering the dose of anti-cancer drugs well below the standard treatment threshold has shown promise in improving tumours’ response to...
Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers....
Studies reported at ESMO 2024 have revealed new groups of women with early-stage (1) and cervical cancers (2) who gain clinically meaningful benefit...
Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with...
Macquarie University researchers have discovered new information about how oral cancer cells may block the body's immune response. This could lead to...
Learn about the disparities in immunotherapy access for Black patients with triple-negative breast cancer (TNBC) compared to white patients.
Immunotherapy is a type of cancer treatment that uses the body's own immune system to help fight cancer. This is by stimulating the immune response to...
Researchers discovered a drug that safely and effectively helped cancer patients when they suffered from cachexia, a common condition related to...
Researchers at UCLA Health have discovered a molecule that shows promise in restoring memory and cognitive function in mice with Alzheimer’s-like...